SCHOTT offers a wide range of prefillable syringes, including completely sterile syringe sets, ready for the filling process.
SCHOTT Pharmaceutical Systems helps people around the world protect, access and use the medicine they need as safely and conveniently as possible.
As a market leader in primary packaging made of glass and polymer, we are safeguarding and advancing the integrity of injectable solutions and more. We are pioneers with unsurpassed quality, safety and reliability.
Strong purpose-driven mindset
Health and wellbeing are more precious to people than anything else. Contributing to them is a meaningful purpose and task. This is what we are here for. We are experts in our fields and a true partner to the pharmaceutical industry. In everything we do, we think customers, users and patients first.
Human health matters
User centricity, collaboration, smartness and visions are the core values of all SCHOTT Pharma employees. They guide us in designing solutions to ensure that medicines are safe and easy to access for people around the world. Together with you – our customers and partners – we strive for the best patient experience. For a simple reason: human health matters.
SCHOTT Pharmaceutical Systems
With worldwide more than 600 production lines in 13 countries. These sites are producing more than 10 billion syringes, cartridges, ampoules, vials and special products consist of tubing glass or polymer.
- GMP compliant production network for secure supply worldwide 18 converting sites in 13 countries
- Three production lines: Glass primary packaging including ampoules, cartridges, vials, syringes; SCHOTT TOPPAC; SCHOTT IQ
- Wide range of syringes, cartridges, ampoules and vials, as well as individual solutions for customers
- Innovative packaging solutions with high-quality raw material: FIOLAX® glass and COC polymer
- Coated packaging or innovative syringe systems for highly sensitive drugs (biotech)
- Continuous R&D, state-of-the-art technologies and production processes
- SCHOTT pharma services to support pharmaceutical companies with lab analytics and more
The origin of glass products are the high-quality SCHOTT FIOLAX® Tubes. Glass is the preferred basis for pharmaceutical primary packaging. Due to its characteristics as inert material, glass reduces the probability of reactions between drugs and container. Glass also prevents gas and other volatile substances to reach the drug. The quality of the glass is the main aspect, how effective its inert characteristics are.
COC (Cyclo-Olefin-Copolymer) high-tech-polymer provides excellent characteristics for packaging pharmaceutical applications as an alternative for glass. It is a fracture-proof, lightweight and transparent material. SCHOTT has experiences with COC polymer for decades.
The most important barrier properties are a lower particle level compared to glass syringes and no release of ions and heavy metal. Even in small containers, the storage of drugs is possible. Due to the high flexibility at the heating process, we are able to fulfil individual customer needs with our brand TOPPAC®.
Ampoules are one of the most common packaging solutions worldwide. SCHOTT's glass ampoules ensure that the medication is only in contact with glass, and the packaging is 100% tamperproof.
The recent spike in market recalls for injectable drug products due to visible flaky particles associated with 'glass delamination' demonstrates the need to solve these problems.
SCHOTT opened the first GMP-compliant pharmaceutical packaging production facility in Russia in May 2011. The plant is located at Zavolzhe near Nizhny Novgorod city in Russia.
With vials capable of holding up to 2 billion vaccination doses, SCHOTT is supporting the world’s struggle against Covid-19.
The CEOs of SCHOTT, Stevanato Group, and Gerresheimer have pledged the ample supply of pharmaceutical containers for any Covid-19 vaccine and treatment developed, no matter the patient or region of the world they reside.
Each drug formulation is unique, as is every patient. Especially high-potency medicines breaking into the market have exacting pharma packaging must guarantee drug stability.
The 2.25mL long syringe was manufactured for highly viscous biologics, administered by using an autoinjector.
By breaking ground, speciality glass manufacturer SCHOTT has given the preliminary signal for the erection of a production facility for sterile polymer pharmaceutical primary packaging at its Müllheim site, Germany.
SCHOTT Pharmaceutical Systems has announced it will be exhibiting at CPhI Worldwide 2019.
The future of augmented reality (AR) and mixed reality (MR) is right in front of your eyes. SCHOTT has unveiled the latest addition to SCHOTT RealView™, a product portfolio of high-quality optical glass wafers designed for the realisation of a new era of consumer-grade smart glasses.
International technology group SCHOTT and French engineering firm SINCAD have signed an exclusive cooperation and development agreement aimed at strengthening SCHOTT’s expertise in the field of camera inspection systems.
People undergoing facial plastic surgery expect flawless results. Yet aesthetic injections are not a simple task. That is where SCHOTT TOPPAC® cosmetic syringes come into play.
Complex biological drugs offer hope for some of the hardest-to-treat conditions, from cancer to chronic disease. That promise comes with challenges. For example, biologics requires special packaging that will maintain the drug stability and ensure patient safety.
SCHOTT is to expand its TopPac polymer syringes range with through launching a 20ml unit that can be used in combination with syringe pumps for infusion therapy.
SCHOTT has announced that it plans to achieve further growth in its prefillable syringe line.
SCHOTT is to launch SCHOTT Vials DC, which are pharmaceutical vials that, for the first time ever, allows for the risk of delamination to be determined based on threshold values.
With adaptiQ, SCHOTT will be unveiling a new concept of ready-to-use pharmaceutical vials that has been modified in close cooperation with filling line manufacturers to meet the process requirements of the pharmaceutical industry.
SCHOTT Pharmaceutical Systems has unveiled plans for the significant expansion of its Hungarian site Lukácsháza, which manufactures pharmaceutical primary packaging.
SCHOTT Pharmaceutical Systems has presented the world's first cartridges developed specifically for the use on high-speed filling lines at the pharmaceutical trade fair Interphex in New York.
SCHOTT has been expanding its manufacturing capacity for small size (1ml to 10 ml) SCHOTT TopPac® syringes in order to address the increasing worldwide demand for prefillable polymer syringes.
SCHOTT Pharmaceutical Systems has unveiled plans for expanding production capacities by 20% at its facility in Bekasi, Indonesia.
SCHOTT has expanding its range of analyses offered due to an increasing demand for laboratory services related to 'extractables and leachables' ('E&L').
SCHOTT continues to strengthen its position in the Asian pharmaceutical market with the opening of a high-tech facility in India.
SCHOTT Pharmaceutical Packaging continues to experience growth in Russia and now plans to increase the production capacities at its plant in in Zavolzhe by more than 50%. The manufacturer announced this move today at the Pharmtech trade fair in Moscow.
SCHOTT Pharmaceutical Packaging has released a new, free-to-download white paper which explores ways to minimize the delamination risk of glass containers.
SCHOTT has appointed Christophe Muguet as vice-president of its global syringe business. He leads this area's business activities as part of SCHOTT Pharmaceutical Packaging from the offices in St Gallen, Switzerland.
From 12-18 May, SCHOTT presented its innovative solutions in the area of parenteral packacking for the pharmaceutical industry under the motto 'Your Trusted Partner for Quality Packaging Solutions, Worldwide' at the Interpack 2011 event in Düsseldorf, Germany. On two floors and an
International technology group SCHOTT today officially inaugurated a production site for primary pharmaceutical packaging located in Zavolzhe, near the Russian city of Nizhny Novgorod. The new production site will employ around 60 employees initially and will produce premium quality ampoules and
SCHOTT Pharmaceutical Systems, one of the world's leading suppliers of glass tubing and primary packaging for the pharmaceutical industry, continues to expand its global network. The company will open up a new production plant in Russia this month and plans to further strengthen its position in J
The German technology group SCHOTT and the Japanese company Naigai Glass Industry recently founded a joint venture for pharmaceutical packaging activities in Japan, which came into effect from 1 October 2010. The new company is called SCHOTT NAIGAI K.K. and is based in Osaka, Japan, where Naiga
New drugs generate new challenges in the field of pharmaceutical packaging. "Biomolecules, for instance, are being used today in over 50% of all product developments in pharmaceutical therapy," says Dr Claudia Dietrich, product manager for vials and coating at SCHOTT in St. Gallen, Switzerlan
Recently, the US Food and Drug Administration (FDA) addressed a warning to a US pharmaceuticals company, when third-party manufactured glass vials were found to contain glass particles upon inspection. SCHOTT Pharmaceutical Packaging Division, part of the multinational technology-based
With a new manufacturing facility for premium-quality ampoules and vials in Zavolzhe, near the Russian city of Nizhny Novgorod, the German technology company and global quality leader SCHOTT will extend its leading position in the area of high-quality pharmaceutical packaging in Russia. At the 'P